Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. März 2022 17:37 ET | Quelle: Telix Pharmaceuticals Limited

ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment

MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that ZIRCON (Zirconium in Renal Cancer Oncology,...
22. Oktober 2020 01:00 ET | Quelle: Telix Pharmaceuticals Limited

First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey

MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...
17. August 2020 20:00 ET | Quelle: Telix Pharmaceuticals Limited

First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan

TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that...
25. Juni 2018 06:47 ET | Quelle: Telix Pharmaceuticals Limited

Telix and Isologic conclude manufacturing agreement for North America

MELBOURNE, Australia and MONTREAL, June 25, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix Group”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
03. Dezember 2017 17:00 ET | Quelle: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Appointed Dr. Bernard Lambert as President of Telix Pharmaceuticals (US) Inc.

MELBOURNE, Australia and INDIANAPOLIS, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...